How Do Analysts Perceive Resmed Inc (RMD)?

Resmed Inc (RMD) saw an uptrend of 945085% in the recent trading with $1020000.0 being its most recent. The current price level -1.95% lower than the highest price of $263.05 marked by the stock while trading over the past 52-weeks, whereas it is 43.01% higher than the lowest price of $180.34 the company dropped to over past 52-weeks. The latest news story on RMD appeared in (Zacks) under the title “All You Need to Know About ResMed (RMD) Rating Upgrade to Buy” on Today.

Do analysts rate it as a buy, sell or hold?

Irrespective of recent performance, what’s important is what the future holds. In uncertain economic times, a clear picture is difficult to get. Analysts generally have a good understanding of the market works, which gives them a leg up in making predictions. Currently, the stock has been recommended as Strong Buy by 19 of the brokerage firms. Analyst ratings are often compiled into a single score from 1 to 5. The score of 1 signifies buy or strong buy, the score of 2 signifies outperform, the score of 3 means hold, and the score of 4 indicates underperform. The simple numeric range of brokerage firm referenced at the scale of 1 to 5 reads a current average recommendation of 1.93 for the stock.

Resmed Inc Earnings – What Happened With RMD

Coming around sales and income figures on RMD Stock Income Statement, public trading companies under normal circumstances post earnings and revenues near to average estimates by the Wall Street analysts, but those could came either above or below estimates and known as surprise factor.

Resmed Inc – Insider Activity and Holdings

Investors get the exact data about the key information of institutional ownership in a listed company through its 13F filings at the Stock Exchange Commission (SEC). The total number of common shares currently owned by the public is 146.87 million. RMD does have institutional investors; and they hold 66.00% of the stock.

As on 2024-06-30, VANGUARD GROUP INC was the top most holder in Resmed Inc (NYSE:RMD) with an ownership of 17.9 million shares of the company or 12.1841 of the stake worth $3.43 billion. The filing also reveals BLACKROCK INC. as the second largest holder in the company with a control over 7.9583 of the outstanding shares. Its stake is worth $2.24 billion for having 11.69 million shares in hand.

STATE STREET CORP also came holding a key position in the company during the recent quarter and it now holds 4.1825 of the outstanding shares. With this there are now 1319.0 institutions which have possession in RMD’s shares.

Key Metrics forRMD

The liquidity is a key characteristic of any stock and is the main point of focus of both short-term as well as long term investors before start trading into a stock. In recently reported quarter, Resmed Inc has a debt to equity ratio of 0.15.

Technical Analysis of Resmed Inc (NYSE:RMD) stock

To comprehend better with the trade moves and investors’ behavior, exploring the short, medium and long term technical indicators along with average volume of a stock is an effective way to make use of. When looking into those indicators for Resmed Inc (RMD), we notice that the stock’s 20-day average volume is at 723,160 shares and 100% of short term indicators are suggesting the stock as Buy. Medium term indicators at an average of 100% are spotting the stock at Buy with its 50-day average volume of 948,298 shares. And to end, RMD’s 100-day average volume is 1,017,033 shares with 50% of the long-term indicators pointing towards Buy for the stock.

The Baxter Report
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.